Help us improve Portfolio Grader.

Help us improve Portfolio Grader.

Blue Chip Growth

Stock Report: "BioScrip, Inc." (BIOS) Report Updated: Feb 08, 2016 | Print This Page

Get more stock ratings by Louis Navellier

"BioScrip, Inc." (BIOS)

Rating: Sell Volatility: Moderate
Total Grade: D Industry: Health Care Providers & Services
Competitors: AFAM, AHS, USPH, CHE

Stock Analysis

Rating: Monthly View

February March April May June July August September October November December January

Rating: Weekly View

This Week: D down downgrade
Last Week: C same upgrade
Two Weeks Ago: D up no change
service keys

"BioScrip, Inc."© quotemedia

Company Profile

BioScrip, Inc. provides pharmacy and home health services in the United States. Its Infusion/Home Health Services segment offers home infusion services that include the intravenous administration of medications to treat various acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic conditions, cancer, pain, and palliative care; and home infusion therapies comprising parenteral nutrition, enteral nutrition, antimicrobial therapy, chemotherapy, immune globulin therapy, pain management, hemophilia, and respiratory therapy/home medical equipment. This segment also provides home health services, such as skilled nursing, wound care, oncology nursing and infusion nursing, rehabilitation services, occupational therapy and speech language pathology, medical social services, home health aide services, private duty nursing care, therapy visits, and hospice services to patients suffering from chronic and acute illnesses, those in recovery from surgical procedures, and those who require monitoring or care for other reasons. The company’s Pharmacy Services segment provides traditional and specialty medications for the treatment of various diseases and medical conditions, such as rheumatoid arthritis, Crohn’s disease, multiple sclerosis, psoriasis, short stature, cancer, immune mediated diseases, and HIV/AIDS; hepatitis A, B, C, and related complications; anemias and cytopenias, and to bind excess iron post blood transfusions; and to treat children born prematurely and with incomplete pulmonary and/or cardiac function. This segment also offers specialty therapy management, prescription discount card programs, and pharmacy data services. As of December 31, 2011, the company had 110 locations in 29 states and the District of Columbia, including 30 community pharmacy locations, 32 home nursing locations, 3 mail service facilities, and 45 home infusion locations. BioScrip, Inc. was founded in 1993 and is based in Elmsford, New York.

Recent News: "BioScrip, Inc."